International Stand Alone Meeting 2009 - Reducing Cardiovascular Risk

Saturday 3rd October 2009

Day 2 - Guidelines and Outcomes

Berlin, Germany

The following presentations made at the International Stand Alone Meeting 2009 are available as webcasts under the respective links:

Welcome and opening remarks

Toshiro Fujita, Japan

Setting the scene

Michael Böhm, Germany

Current trends and expectations in guidelines for antihypertensive treatment

Suzanne Oparil, USA

Developing guidelines: the conflict between evidence base and interpretation

Giuseppe Mancia, Italy

The role of fixed-dose combinations as first-line therapy

Luis M Ruilope, Spain

Panel discussion

All

Introduction to debates

Michael Weber, USA

Debate: There is no such thing as the ‘class effect’

Björn Dahlöf, Sweden, and Adrian Brady, UK

Adherence is underrated in guidelines

Suzanne Oparil, USA, and Arya M Sharma, Canada

Summary and close

Michael Böhm, Germany

^* Telmisartan is currently only approved for the treatment of hypertension

These webcasts follow the presentations held on occasion of the International Stand Alone Meeting 2009 between 1st - 3rd October 2009. They are reproduced here for your personal information. Pursuant to our Terms of Use any sort of reproduction or downloading, in total or in part, is prohibited.